Cellink Competitors and Similar CompaniesClear all
Autolus's competitors and similar companies include Centogene.
 Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Centogene Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases. | |
Founding Date | Founding Date 2014 | Founding Date 2005 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations London, GB HQ London, GB | Locations Rostock, DE HQ Wien, AT Berlin, DE Frankfurt Am Main, DE Hamburg, DE Greater Noida, IN Dubai, AE see more |
Employees | Employees 647 | Employees 80823% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 9.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) €48.5m (FY, 2023) |
Cost of goods | Cost of goods $86.6m (FY, 2025) | Cost of goods €29.1m (FY, 2023) |
Gross profit | Gross profit ($10.7m) (FY, 2025) | Gross profit €23.7m (FY, 2023) |
Net income | Net income ($287.5m) (FY, 2025) | Net income (€35.5m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 281.7m | Total funding raised $ 29.6m |
For sources of this data, please see the company profile
View Company Profiles
Centogene
HQ
Rostock, DE
Employees
808↑ 23% increase
Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases.
View company